Opportunity ID: 347120

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-23-018
Funding Opportunity Title: Defining Mechanisms of HIV Induced Inflammation and Immune Activation During Suppressive Antiretroviral Therapy (ART) (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 24, 2023
Last Updated Date: Mar 24, 2023
Original Closing Date for Applications: Aug 02, 2023
Current Closing Date for Applications: Aug 02, 2023
Archive Date: Sep 07, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Small businesses
Native American tribal governments (Federally recognized)
County governments
Private institutions of higher education
For profit organizations other than small businesses
Public and State controlled institutions of higher education
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages research focused on defining the molecular mechanisms by which HIV proteins and/or nucleic acids induce inflammation, immune activation and HIV persistence during viral suppression as well as on developing novel therapeutic strategies to mitigate or eliminate the effects of continued HIV expression.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-23-018.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 347120 Full Announcement-RFA-AI-23-018 -> RFA-AI-23-018-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00280802 Jul 02, 2023 Aug 02, 2023 View

Package 1

Mandatory forms

347120 RR_SF424_5_0-5.0.pdf

347120 PHS398_CoverPageSupplement_5_0-5.0.pdf

347120 RR_OtherProjectInfo_1_4-1.4.pdf

347120 PerformanceSite_4_0-4.0.pdf

347120 RR_KeyPersonExpanded_4_0-4.0.pdf

347120 PHS398_ResearchPlan_5_0-5.0.pdf

347120 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

347120 RR_Budget_3_0-3.0.pdf

347120 RR_SubawardBudget30_3_0-3.0.pdf

347120 PHS398_ModularBudget_1_2-1.2.pdf

347120 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T14:02:13-05:00

Share This Post, Choose Your Platform!

About the Author: